Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Ascentage Pharma Group Inc.
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Nebraska
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Rutgers, The State University of New Jersey
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
University Health Network, Toronto
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
Vanderbilt-Ingram Cancer Center
University of Maryland, Baltimore